The PE Ratio as of May 2025 (TTM) for Santhera Pharmaceuticals Holding AG (SPHDF) is -3.97

According to Santhera Pharmaceuticals Holding AG’s latest financial reports and current stock price. The company's current PE Ratio is -3.97. This represents a change of 330.32% compared to the average of -0.92 of the last 4 quarters.

Santhera Pharmaceuticals Holding AG (SPHDF) Historical PE Ratio (quarterly & annually)

How has SPHDF PE Ratio performed in the past?

The mean historical PE Ratio of Santhera Pharmaceuticals Holding AG over the last ten years is 5.50. The current -3.97 PE Ratio has changed -7318.74% with respect to the historical average. Over the past ten years (40 quarters), SPHDF's PE Ratio was at its highest in in the December 2015 quarter at 10.91. The PE Ratio was at its lowest in in the December 2014 quarter at -21.83.

Santhera Pharmaceuticals Holding AG (SPHDF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Santhera Pharmaceuticals Holding AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Santhera Pharmaceuticals Holding AG (SPHDF) Average PE Ratio

How has SPHDF PE Ratio performed in the past?

The current PE Ratio of Santhera Pharmaceuticals Holding AG (SPHDF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Santhera Pharmaceuticals Holding AG (SPHDF) PE Ratio vs. Peers

How is SPHDF’s PE Ratio compared to its peers?

Santhera Pharmaceuticals Holding AG’s PE Ratio is greater than IDEAYA Biosciences, Inc. (-4.99), greater than AnaptysBio, Inc. (-4.45), less than MeiraGTx Holdings plc (-2.38), less than Keros Therapeutics, Inc. (135.10), less than Homology Medicines, Inc. (-0.45), less than Fusion Pharmaceuticals Inc. (0), greater than GH Research PLC (-17.31), greater than Inventiva S.A. (-14.29), less than Decibel Therapeutics, Inc. (-1.06), less than Genfit S.A. (-1.95), less than Lexaria Bioscience Corp. (120.28), less than Navidea Biopharmaceuticals, Inc. (-1.92), less than ZyVersa Therapeutics, Inc. (-0.00), less than Biodexa Pharmaceuticals Plc (-0.00), less than Oncorus, Inc. (-0.00), less than Design Therapeutics, Inc. (-0.04), less than Achilles Therapeutics plc (-3.39), less than Neoleukin Therapeutics, Inc. (-0.89), less than Magenta Therapeutics, Inc. (-0.67), less than Graphite Bio, Inc. (-0.02), less than null (-3.84),

Build a custom stock screener for Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santhera Pharmaceuticals Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santhera Pharmaceuticals Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.